{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:29:53Z","timestamp":1676438993817},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1132,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1365-2133.2012.11119.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T14:49:40Z","timestamp":1343314180000},"page":"227-228","source":"Crossref","is-referenced-by-count":2,"title":["Consider drugs as a cause or an exacerbating factor in patients diagnosed with subacute cutaneous lupus erythematosus!"],"prefix":"10.1093","volume":"167","author":[{"given":"Jeffrey P.","family":"Callen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0046-8177(97)90281-1","article-title":"Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy","volume":"28","author":"Crowson","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.137.9.1196","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases","volume":"137","author":"Callen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archdermatol.2010.258","article-title":"Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy","volume":"146","author":"Funke","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archdermatol.2011.290","article-title":"Tissue eosinophilia: not an indicator of drug-induced subacute cutaneous lupus erythematosus","volume":"148","author":"Hillesheim","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB9|cit9","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11119.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2340\/00015555-1115","article-title":"Recurrent subacute cutaneous lupus erythematosus following exposure to different drugs","volume":"91","author":"Liakou","year":"2011","journal-title":"Acta Derm Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11119.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11119.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:56:33Z","timestamp":1676382993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/2\/227\/6614024"}},"subtitle":["Editorial"],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11119.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}